SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has completed the first tranche of …
...
READ MOREMarch 7, 2019
SQI Diagnostics' Partner Launches Two New Direct-to-Consumer Tests
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics today announces two new product launches within the imaware™ family of …
...
READ MOREJanuary 28, 2019
SQI Diagnostics' Direct-to-Consumer Partner Launches At-Home Celiac Disease Awareness Test
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics today announces the launch of the imaware™ at-home test for celiac …
...
READ MOREDecember 11, 2018
SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has completed the first tranche of …
...
READ MOREAugust 17, 2018
SQI Diagnostics and Microdrop Launch Revolutionary Disease Awareness Tests for Direct-to-Consumer Market
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”), and Microdrop LLC, a direct to consumer healthcare company focused …
...
READ MOREMay 11, 2018
RELATED POSTS
Copyright 2025 The Venture Report